ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,252,886 | +28.0% | 95,349 | +22.8% | 0.00% | 0.0% |
| Q2 2023 | $978,629 | +35.8% | 77,669 | +39.1% | 0.00% | 0.0% |
| Q1 2023 | $720,636 | -16.9% | 55,820 | +13.6% | 0.00% | 0.0% |
| Q4 2022 | $866,865 | -88.9% | 49,142 | -90.4% | 0.00% | -85.7% |
| Q3 2022 | $7,797,000 | -4.4% | 511,981 | -6.9% | 0.01% | 0.0% |
| Q2 2022 | $8,153,000 | -5.4% | 549,790 | -37.4% | 0.01% | -12.5% |
| Q4 2019 | $8,620,000 | -39.5% | 878,262 | -32.3% | 0.01% | -42.9% |
| Q3 2019 | $14,250,000 | -16.6% | 1,297,777 | -11.6% | 0.01% | -17.6% |
| Q2 2019 | $17,078,000 | +33.8% | 1,468,470 | +9.7% | 0.02% | +30.8% |
| Q1 2019 | $12,767,000 | +19.6% | 1,338,255 | +20.9% | 0.01% | +8.3% |
| Q4 2018 | $10,671,000 | +657.9% | 1,106,984 | +1018.7% | 0.01% | +1100.0% |
| Q3 2017 | $1,408,000 | -60.8% | 98,953 | -64.9% | 0.00% | -75.0% |
| Q2 2017 | $3,592,000 | +2.5% | 281,537 | +1.8% | 0.00% | 0.0% |
| Q1 2017 | $3,506,000 | +26.2% | 276,534 | +1.6% | 0.00% | +33.3% |
| Q4 2016 | $2,779,000 | -21.5% | 272,202 | +1.3% | 0.00% | -25.0% |
| Q3 2016 | $3,540,000 | +9.1% | 268,826 | +5.2% | 0.00% | 0.0% |
| Q2 2016 | $3,244,000 | -64.4% | 255,445 | -63.0% | 0.00% | -63.6% |
| Q1 2016 | $9,125,000 | +172.2% | 690,768 | +217.0% | 0.01% | +175.0% |
| Q4 2015 | $3,352,000 | +26.0% | 217,917 | +1.5% | 0.00% | +33.3% |
| Q3 2015 | $2,661,000 | -15.4% | 214,624 | -6.6% | 0.00% | -25.0% |
| Q2 2015 | $3,144,000 | +26.0% | 229,857 | +10.2% | 0.00% | +33.3% |
| Q1 2015 | $2,495,000 | +297.9% | 208,613 | +324.6% | 0.00% | +200.0% |
| Q4 2014 | $627,000 | +22.0% | 49,130 | +28.2% | 0.00% | 0.0% |
| Q3 2014 | $514,000 | +184.0% | 38,325 | +228.2% | 0.00% | – |
| Q4 2013 | $181,000 | -42.5% | 11,677 | -44.8% | 0.00% | – |
| Q3 2013 | $315,000 | -92.5% | 21,155 | -93.5% | 0.00% | -100.0% |
| Q2 2013 | $4,194,000 | – | 324,123 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |